Please see the full solicitation for complete information about the funding opportunity. Below is a summary assembled by the Research & Innovation Office (RIO).

Program Summary

Through this I-Corps鈩� at NIH program Funding Opportunity Announcement (FOA), NIH and CDC provide administrative supplement awards to currently-funded SBIR and STTR Phase I grantees. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. The program provides three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.

Deadlines

麻豆免费版下载Internal Deadline: 11:59pm MST September 28, 2020

Sponsor Application Deadline: 5:00pm MST November 17, 2020

Internal Application Requirements (all in PDF format)

  • 1) I-Corps Team (1 page maximum): describe the I-Corps team and provide the rationale for its formation, focusing on the team members' entrepreneurial expertise, experience bringing previous products to the market, relevance of the team's background to the innovation effort, and their experience in collaborating on previous projects; provide clear statements to indicate that all team members are able to meet the time-intensive requirements of the training program (expected to be at least 20 hours per week per team member); briefly describe how the team will benefit from the I-Corps at NIH program; discuss the team's willingness to modify/refine the overall commercialization strategy, based on knowledge gained during the course of the I-Corps Program.听
  • 2) Potential Commercial Impact (1 page maximum): briefly describe how this research has led the team to believe that a commercial opportunity exists for the SBIR/STTR Phase I project moving forward; provide a brief profile of a typical customer of the proposed innovation; describe the customer need(s) that will be met by the proposed innovation; describe how the customer currently meets those needs; what is the competitive advantage that is offered by the proposed product or service?; how much would a customer pay for the solution (current best estimate)?
  • 3) Project Plan (I page maximum): describe the stage of development for the SBIR/STTR Phase I project that is currently under development (proof-of-concept, prototype stage, etc.); provide a brief description of the proof-of-concept or technology demonstration that will be provided by the end of the SBIR/STTR Phase I project; describe the next steps that the company will take to advance the project closer toward commercialization, assuming the outcomes of the SBIR/STTR Phase I award are promising.
  • 4) Budget Overview (1 page maximum): A basic budget outlining project costs is sufficient; detailed OCG budgets are not required.

To access the online application, visit:

Eligibility

To apply for an administrative supplement award under this FOA, applicants must have received a prior SBIR or STTR Phase I grant from one of the听. The predicate Phase I grant must extend (at least) through the Lessons Learned workshop of the cohort schedule, and the grant should have remaining budget and R&D activities that extend at least until that date. Grant awards currently under a no-cost extension are eligible, provided they meet the above criteria. NIH- and CDC-funded SBIR Phase I contractors are not eligible to apply under this FOA.

Limited Submission Guidelines

Only one supplement application per parent SBIR/STTR Phase I award is allowed under this FOA. Applicant organizations with multiple, currently-active SBIR and/or STTR Phase I awards from the different participating Institutes and Centers listed on this FOA may choose only ONE award to serve as the predicate for an administrative supplement to support the I-Corps at NIH program activity. The NIH and CDC will not fund multiple administrative supplement awards to the same applicant organization under this FOA.

Award Information

NIH and CDC intend to commit up to $1,200,000 in each fiscal year (FY 2019-2021) to fund up to 24 awards per year (72 awards over three fiscal years.)

Review Criteria

Please note the by which NIH will review applications as you develop your internal proposal.